The Valley Desk

NCT05831111 · Interventional trial

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

Overall registry status Completed

Phase 1

Conditions Epstein-Barr Virus Infection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov